Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance

Alexandra Lebedeva, Ekaterina Belova, Alexandra Kavun, Anastasiia Taraskina, Michele Bartoletti, Ivan Bièche, Giuseppe Curigliano, Célia Dupain, Alejandro Rios-Hoyo, Maud Kamal, Claudio Luchini, Stanislav Poyarkov, Christophe Le Tourneau, Egor Veselovsky, Vladislav Mileyko, Maxim Ivanov

Open source

DOI: 10.1007/s40291-024-00748-4
Published: 2024-10-05
Container: Molecular Diagnosis & Therapy
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40291-024-00748-4,
  title = {Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance},
  author = {Alexandra Lebedeva and Ekaterina Belova and Alexandra Kavun and Anastasiia Taraskina and Michele Bartoletti and Ivan Bièche and Giuseppe Curigliano and Célia Dupain and Alejandro Rios-Hoyo and Maud Kamal and Claudio Luchini and Stanislav Poyarkov and Christophe Le Tourneau and Egor Veselovsky and Vladislav Mileyko and Maxim Ivanov},
  year = {2024},
  journal = {Molecular Diagnosis \&amp; Therapy},
  doi = {10.1007/s40291-024-00748-4},
  url = {https://doi.org/10.1007/s40291-024-00748-4}
}

RIS

TY  - JOUR
TI  - Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance
AU  - Alexandra Lebedeva
AU  - Ekaterina Belova
AU  - Alexandra Kavun
AU  - Anastasiia Taraskina
AU  - Michele Bartoletti
AU  - Ivan Bièche
AU  - Giuseppe Curigliano
AU  - Célia Dupain
AU  - Alejandro Rios-Hoyo
AU  - Maud Kamal
AU  - Claudio Luchini
AU  - Stanislav Poyarkov
AU  - Christophe Le Tourneau
AU  - Egor Veselovsky
AU  - Vladislav Mileyko
AU  - Maxim Ivanov
PY  - 2024
JO  - Molecular Diagnosis &amp; Therapy
DO  - 10.1007/s40291-024-00748-4
UR  - https://doi.org/10.1007/s40291-024-00748-4
ER  -

APA

Lebedeva, A., Belova, E., Kavun, A., Taraskina, A., Bartoletti, M., Bièche, I., Curigliano, G., Dupain, C., Rios-Hoyo, A., Kamal, M., Luchini, C., Poyarkov, S., Tourneau, C. L., Veselovsky, E., Mileyko, V., & Ivanov, M. (2024). Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance. Molecular Diagnosis & Therapy. https://doi.org/10.1007/s40291-024-00748-4

Source records

crossref · retrieved 2026-09-27T07:43:42.326Z